177 related articles for article (PubMed ID: 31131577)
1. Virus-Like Particle Based Vaccine Provides High Level of Protection Against Homologous H5N8 HPAIV Challenge in Mule and Pekin Duck, Including Prevention of Transmission.
Tatár-Kis T; Dán Á; Felföldi B; Bálint Á; Rónai Z; Dauphin G; Pénzes Z; El-Attrache J; Gardin Y; Palya V
Avian Dis; 2019 Mar; 63(sp1):193-202. PubMed ID: 31131577
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Clade 2.3.2 H5-Recombinant Baculovirus Vaccine in Protecting Muscovy and Pekin Ducks from Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Infection.
Sultan HA; Arafa AE; Talaat S; Gaballa AA; Kilany WH; Elfeil WK; Shehata AA; Amarin N
Avian Dis; 2019 Mar; 63(sp1):219-229. PubMed ID: 31713400
[TBL] [Abstract][Full Text] [Related]
3. Rapid Construction and Immunogenicity Testing of a Novel H5 Virus-Like Particle Prototype Vaccine Against Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Virus.
Pénzes Z; Czeglédi A; Nagy Z; Kollár A; Tóth Á; Misák F; Rendes K; Ivók M; Gyimesi R; Lovrecz G; Tretyakova I; El-Attrache J; Palya V; Pushko P
Avian Dis; 2019 Mar; 63(sp1):203-208. PubMed ID: 31131578
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks.
Niqueux É; Flodrops M; Allée C; Lebras MO; Pierre I; Louboutin K; Guillemoto C; Le Prioux A; Le Bouquin-Leneveu S; Keïta A; Amelot M; Martenot C; Massin P; Cherbonnel-Pansart M; Briand FX; Schmitz A; Cazaban C; Dauphin G; Delquigny T; Lemière S; Watier JM; Mogler M; Tarpey I; Grasland B; Eterradossi N
Vaccine; 2023 Jan; 41(1):145-158. PubMed ID: 36411134
[TBL] [Abstract][Full Text] [Related]
5. Genetic Determinants for Virulence and Transmission of the Panzootic Avian Influenza Virus H5N8 Clade 2.3.4.4 in Pekin Ducks.
Scheibner D; Breithaupt A; Luttermann C; Blaurock C; Mettenleiter TC; Abdelwhab EM
J Virol; 2022 Jul; 96(13):e0014922. PubMed ID: 35670594
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Two Licensed Avian Influenza H5 Vaccines Against Challenge with a 2015 U.S. H5N2 clade 2.3.4.4 Highly Pathogenic Avian Influenza Virus in Domestic Ducks.
Pantin-Jackwood MJ; DeJesus E; Costa-Hurtado M; Smith D; Chrzastek K; Kapczynski DR; Suarez DL
Avian Dis; 2019 Mar; 63(1):90-96. PubMed ID: 31251524
[TBL] [Abstract][Full Text] [Related]
7. Ducks Are Susceptible to Infection with a Range of Doses of H5N8 Highly Pathogenic Avian Influenza Virus (2016, Clade 2.3.4.4b) and Are Largely Resistant to Virus-Specific Mortality, but Efficiently Transmit Infection to Contact Turkeys.
Slomka MJ; Puranik A; Mahmood S; Thomas SS; Seekings AH; Byrne AMP; Núñez A; Bianco C; Mollett BC; Watson S; Brown IH; Brookes SM
Avian Dis; 2019 Mar; 63(sp1):172-180. PubMed ID: 31131575
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
[TBL] [Abstract][Full Text] [Related]
9. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains.
Azab AA; Yehia N; Makhareta M; Samir M; Shoukry A; Elhalem Mohamed AA; Alhag SK; Alwabli AS; El-Saadony MT; El-Tarabily KA; Soliman MA
Poult Sci; 2023 Oct; 102(10):102952. PubMed ID: 37634266
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a Recombinant Turkey Herpesvirus AI (H5) Vaccine in Preventing Transmission of Heterologous Highly Pathogenic H5N8 Clade 2.3.4.4b Challenge Virus in Commercial Broilers and Layer Pullets.
Palya V; Tatár-Kis T; Walkóné Kovács E; Kiss I; Homonnay Z; Gardin Y; Kertész K; Dán Á
J Immunol Res; 2018; 2018():3143189. PubMed ID: 30584541
[TBL] [Abstract][Full Text] [Related]
12. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
[TBL] [Abstract][Full Text] [Related]
13. Infectivity, transmission and pathogenicity of H5 highly pathogenic avian influenza clade 2.3.4.4 (H5N8 and H5N2) United States index viruses in Pekin ducks and Chinese geese.
Pantin-Jackwood MJ; Costa-Hurtado M; Bertran K; DeJesus E; Smith D; Swayne DE
Vet Res; 2017 Jun; 48(1):33. PubMed ID: 28592320
[TBL] [Abstract][Full Text] [Related]
14. Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers.
El-Shall NA; Awad AM; Sedeik ME
Res Vet Sci; 2021 Nov; 140():125-133. PubMed ID: 34425414
[TBL] [Abstract][Full Text] [Related]
15. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
[TBL] [Abstract][Full Text] [Related]
16. Transmission dynamics between infected waterfowl and terrestrial poultry: Differences between the transmission and tropism of H5N8 highly pathogenic avian influenza virus (clade 2.3.4.4a) among ducks, chickens and turkeys.
Puranik A; Slomka MJ; Warren CJ; Thomas SS; Mahmood S; Byrne AMP; Ramsay AM; Skinner P; Watson S; Everett HE; Núñez A; Brown IH; Brookes SM
Virology; 2020 Feb; 541():113-123. PubMed ID: 32056709
[TBL] [Abstract][Full Text] [Related]
17. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
[TBL] [Abstract][Full Text] [Related]
18. Pathobiology of Clade 2.3.4.4 H5Nx High-Pathogenicity Avian Influenza Virus Infections in Minor Gallinaceous Poultry Supports Early Backyard Flock Introductions in the Western United States in 2014-2015.
Bertran K; Lee DH; Pantin-Jackwood MJ; Spackman E; Balzli C; Suarez DL; Swayne DE
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794040
[TBL] [Abstract][Full Text] [Related]
19. Domestic ducks play a major role in the maintenance and spread of H5N8 highly pathogenic avian influenza viruses in South Korea.
Kwon JH; Bahl J; Swayne DE; Lee YN; Lee YJ; Song CS; Lee DH
Transbound Emerg Dis; 2020 Mar; 67(2):844-851. PubMed ID: 31675474
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl.
Palya V; Kovács EW; Tatár-Kis T; Felföldi B; Homonnay ZG; Mató T; Sato T; Gardin Y
Avian Dis; 2016 May; 60(1 Suppl):210-7. PubMed ID: 27309057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
